Patent · US Active

Exendin agonist compounds

US7696161B2 · kind B2 · utility

42Cited by
16References
48Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 25, 2007
Grant dateApr 13, 2010
Priority date
Expiry dateSep 4, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel exendin agonist compounds are provided. These compounds are useful in treating diabetes and conditions which would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.